Independent verification of the MU settings and dose calculation of IMRT treatment plans is an important step in the IMRT quality assurance ͑QA͒ procedure. At present, the verification is mainly based on experimental measurements, which are time consuming and labor intensive. Although a few simplified algorithms have recently been proposed for the independent dose ͑or MU͒ calculation, head scatter has not been precisely taken into account in all these investigations and the dose validation has mainly been limited to the central axis. In this work we developed an effective computer algorithm for IMRT MU and dose validation. The technique is superior to the currently available computer-based MU check systems in that ͑1͒ it takes full consideration of the head scatter and leaf transmission effects; and ͑2͒ it allows a precise dose calculation at an arbitrary spatial point instead of merely a point on the central axis. In the algorithm the dose at an arbitrary spatial point is expressed as a summation of the contributions of primary and scatter radiation from all beamlets. Each beamlet is modulated by a dynamic modulation factor ͑DMF͒, which is determined by the MLC leaf trajectories, the head scatter, the jaw positions, and the MLC leaf transmission. A three-source model was used to calculate the head scatter distribution for irregular segments shaped by MLC and the scatter dose contributions were computed using a modified Clarkson method. The system reads in MLC leaf sequence files ͑or RTP files͒ generated by the Corvus ͑NOMOS Corporation, Sewickley, PA͒ inverse planning system and then computes the doses at the desired points. The algorithm was applied to study the dose distributions of several testing intensity modulated fields and two multifield Corvus plans and the results were compared with Corvus plans and experimental measurements. The final dose calculations at most spatial points agreed with the experimental measurements to within 3% for both the specially designed testing fields and the clinical intensity modulated field. Furthermore, excellent agreement ͑mostly within Ϯ3.0%͒ was also found between our independent calculation and the ion chamber measurements at both central axis and off-axis positions for the multifield Corvus IMRT plans. These results indicate that the approach is robust and valuable for routine clinical IMRT plan validation.
I. INTRODUCTION
Intensity modulated radiation therapy ͑IMRT͒ is an advanced form of external beam irradiation and represents a radical change in radiation oncology practice. This new process of treatment planning and delivery shows significant potential for improving therapeutic ratio and offers a valuable tool for dose escalation and/or radiation toxicity reduction. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] Intensity modulation adds a new degree of freedom to the conventional radiation treatment, which is based on open or wedged fields, and allows us to modify the dose distribution on an individual beamlet level. A rigorous quality assurance ͑QA͒ procedure is required to ensure what has been planned on an IMRT treatment planning system will be delivered safely and accurately. [11] [12] [13] [14] [15] [16] [17] [18] Among various issues related to plan validation, an important item is the verification of the monitor unit ͑MU͒ settings and the spatial dose distribution of an IMRT treatment plan. The basis for the MU calculation is the correlation between the calibrated dose under a reference condition to the dose delivered by the incident beam for the same MU.
Upon completion of a patient's treatment plan, the system provides a set of MUs for the incident fields. The MU values determine the dose delivered to the tumor and are critically important for the success of radiation treatment. Little is gained if the target volume is underdosed or normal tissue is overdosed because the MUs are not accurately computed. The MU validation or a point dose check is usually performed by a manual calculation in conventional threedimensional ͑3-D͒ radiation therapy. This calculation becomes intractable for an intensity modulated field due to the increased complexity of IMRT. In the last few years, a few groups have developed independent dose calculation algorithms. [19] [20] [21] [22] [23] These algorithms share two common shortcomings: ͑i͒ the influence of the head scatter factors resulting from the irregular segmented fields shaped by MLC has been ignored; 24, 25 and ͑ii͒ the dose calculation point has been limited to the isocenter.
In this work, we present a more general independent point dose calculation algorithm with the inclusion of head scatter and MLC transmission. With the improved modeling of the incident beams, the algorithm allows us to compute accurately the doses, not only at the points along the central axis, but also an arbitrary point in a patient. The algorithm was applied to validate several testing IMRT fields and two Corvus treatment plans. Given the relative simplicity and the robustness of the algorithm, it is anticipated that the technique will have a widespread application in clinical IMRT.
II. METHODS AND MATERIALS

A. Input data
In order to implement the independent dose verification algorithm, three groups of data are required: ͑i͒ primitive machine data, which include tissue maximum ratios ͑TMRs͒, head scatter factors ͑Sc͒, and phantom scatter factors ͑Sp͒ for square fields shaped by jaws, off axis ratios ͑OARs͒ for the maximum field size at several different depths, MLC transmission factors; ͑ii͒ treatment parameters, which include the jaw settings, gantry angles, collimator angles, couch angles, beam energy, the MLC leaf sequences, and the MU settings; and ͑iii͒ the patient's geometry and setup data, which include the coordinates of verification points, external contour of the patient or phantom, beam setup information ͑such as the position of the isocenter͒. The second group of data is contained in the RTP file of the patient treatment plan.
B. Dose calculation with inclusion of head scatter and MLC transmission at an arbitrary spatial point
A few simplified algorithms have been proposed for the independent dose ͑or MU͒ calculation. [19] [20] [21] [22] In this work, we extend the MU calculation formalism proposed by Xing et al. 19 to include the head scatter for dose calculation at an arbitrary spatial point. For a single incident intensity modulated beam, we assume that the treatment field defined by the jaws can be partitioned into M beamlets and that there are K segments in the treatment field. The dose at a given point (x,y,z) in the patient can be expressed as where D m 0 is the dose contribution to the calculation point from the mth beamlet when its intensity is set to unity. It is independent of the shape of the irradiation field and affected only by the positions of the calculation point and the mth beamlet; MU is the total number of monitor units; C m Ј is called the generalized dynamic modulation factor ͑DMF͒, which represents the fractional monitor unit of the mth beamlet in the isocenter plane perpendicular to the central beamline when the beam is assigned with one monitor unit. When the MLC leaf transmission and head scatter effects are taken into account, C m Ј can be calculated by
where f k is the fractional monitor unit of the kth segment, A k is the radiation field shape of the kth segment. Sc m,k is the head scatter factor of the beamlet m in the kth segment, ScЈ is the head scatter factor for the rectangular field defined by the jaws, and ␣ is the average transmission factor, representing the amount of radiation passing through the MLC leaves ͑on average͒ as a percentage of the radiation of a reference open field defined by the jaws. 26 Here, we approximate the transmission for a point under the MLC ͑but inside the rectangular jaw field͒ as the product of the transmission factor, ␣, and the head scatter factor, ScЈ, of the rectangular field set by the jaws. For a Varian machine, ScЈ is a field-specific constant since the jaw settings do not change during the delivery process of an IMRT field. For the 15 MV photon beam from our Clinic 2300C/D ͑Varian Oncology Systems, Palo Alto, CA͒, the average transmission factor is determined to be 1.7%.
The head scatter factor Sc m,k for each beamlet in a segment is calculated using the three-source model reported earlier. 25 In this model, the photon radiation to the point of calculation is treated as if from three effective sources: one source for the primary photons from the target and two extrafocal photon sources for the scattered photons from the primary collimator and the flattening filter, respectively. The intensity distributions of the scatter sources and their positions and the off-axis difference of the scatter radiation are taken into account in the calculation model on a machine and energy specific basis. Source parameters are determined by fitting the head scatter factors to the data of a series of square fields. The head scatter factor for an arbitrarily shaped segment is calculated by integrating the radiation contributed from areas ͑determined by the detector's eye view͒ in the two scatter sources.
A radiation beam is specified by the gantry angle, couch angle, and collimator angle in the machine coordinate system. On the other hand, a point in a patient is more conveniently specified by using a patient-fixed coordinate system. To calculate the absolute dose at an arbitrary point in the patient for a multiple field IMRT plan, a coordinate transform between the patient coordinate system and the machine coordinate system ͑shown in Fig. 1͒ is required. We assume that the coordinates of a verification point are (x,y,z) and (xЈ,yЈ,zЈ) in the patient and machine coordinate systems, respectively, and that the origins of two systems are set at the isocenter. In an isocenter setup treatment, only rotation trans- 
where , ␤, and are the gantry, collimator and couch rotation angles in the IEC convention, respectively. We rewrite Eq. ͑1͒ as the sum of the contributions of the primary radiation and the scatter radiation:
where m 0 is the beamlet͑s͒ contributing to the primary dose of the verification point, (xЈ,yЈ,zЈ), C m 0 Ј is the correspond- Here we should note that there is typically more than one beamlet contributing to the primary dose at a given point of interest. In our algorithm, a finite-size pencil beam method was used to determine the primary intensity. In order to estimate the influence of a beamlet to the primary intensity of the neighboring beamlets, a well-benchmarked Monte Carlo dose calculation system 27 was used to compute the fluence distribution of a 1ϫ1 cm 2 beamlet at the d max with SSDϭ97 cm. It was found that the primary beam intensity at a point of interest ͑POI͒ is predominantly from the central 2ϫ2 cm 2 square. Furthermore, different points ͑beamlet/sub-beamlets͒ on the 2ϫ2 cm 2 square contribute differently to the primary intensity. This is intuitively understandable since their distances to the POI are different. In our calculation we divided each beamlet ͑1ϫ1 cm 2 ͒ into four sub-beamlets ͑0.5ϫ0.5 cm 2 ͒ and our Monte Carlo calculation indicated that the contribution weights to the primary intensity at the center of the 2ϫ2 cm 2 square for the three kinds of sub-beamlets ͑sorted according to the distances to the center of the square͒ in the 2ϫ2 cm 2 (xЈ,yЈ,zЈ) can be calculated using
where C f is the calibration factor of the linac, d eff is the water equivalent depth of the calculation point, Sp͑0͒ and TMR(d eff ,0) are the phantom scatter factor and TMR for zero field size, respectively. POAR(d eff ,xЈ,yЈ) is the primary off-axis ratio at the calculation point, which can be determined using the method presented by Gibbons and Khan. 28 Only the standard central axis data, including output factors, TMRs, and 40ϫ40 cm 2 profiles, are required in the method. A modified Clarkson integration method is used to compute the scatter dose contribution. As was done before, 19 we use square beamlets as the elementary calculation units, which are more natural for MLC-based IMRT. The D s,m 0 (xЈ,yЈ,zЈ) can be obtained by
where r is the distance between the center of the mth beamlet and the projection of the calculation point on the isocenter plane, ⌬rϭl 2 /2r, l is the beamlet size used in the calculation, POAR(d eff ,xЈ,yЈ) is the primary off-axis ratio at the center of the mth beamlet in water equivalent depth d eff . For calculation purposes, a beamlet can be further divided into a number of sub-beamlets. We found that a sub-beamlet size of 0.5ϫ0.5 cm 2 can yield a satisfactory accuracy. In the case of multiple incident beams, the dose at a point can be calculated by simply summing the contributions from all beams, that is,
where index j has been added to label each individual incident beam, and J is the total number of beams.
C. Phantom description and experimental verification
In order to ensure the functionality of the point dose calculation algorithm described above, a series of measurements and Corvus calculations were carried out for several testing cases using either a cubic water equivalent phantom or a cylindrical Lucite phantom of radius 15 cm. Given a phantom and the coordinate of a validation point in the machine coordinate system, (xЈ,yЈ,zЈ), it is straightforward to obtain the effective depth, d eff , defined in Eq. ͑6͒. For the cubic phantom geometry, we have
ϪzЈ͒, ͑9͒
and for the cylindrical phantom, we have
where SSD is the source-skin distance of the calculation point and e is the electron density of the phantom material relative to that of water. A Varian Clinic 2300C/D with a standard 80-leaf MLC and 15 MV photon beam was used to test the independent dose calculation software. Two groups of experiments were performed. The first group includes four specifically designed testing fields and a field from a clinical IMRT plan. The four specially designed fields are ͑i͒ 10ϫ10 cm 2 field formed by five consecutive 2ϫ10 cm 2 subfields ͓Fig. 2͑a͔͒; ͑ii͒ a wedge field ͓Fig. 2͑b͔͒; ͑iii͒ a pyramid field ͓Fig. 2͑c͔͒; and ͑iv͒ an inverse pyramid field ͓Fig. 2͑d͔͒. The MLC leaf sequence file for the first field ͓Fig. 2͑a͔͒ was generated using Varian's Shaper program. For the rest of the fields in Fig.  2 , the Beam Utility Program of the Corvus system was used to take the intensity maps and compute the corresponding dose distributions in the cubic water equivalent phantom. Upon the completion of dose calculations, the leaf sequencing module of the Corvus system was used to generate the leaf sequences for the delivery of the fields.
The dose distributions for the intensity modulated fields shown in Fig. 2 were measured using Kodak XV2 films at different depths perpendicular to the incident beams. The calibration curve for the radiographic films was determined by optical densities measured at d max ϭ3.0 cm for different MU irradiation in the center of a 10ϫ10 cm 2 field with SSD ϭ100 cm. The optical density distributions for the fields were then converted to dose distributions by using the calibration curve. The absolute doses were also measured with a PTW Farmer 0.6 cm 3 ion chamber in the relatively flat parts of the fields for normalization purposes.
In the second group of study, we used a cylindrical Lucite phantom as a surrogate to recalculate the dose distribution of two multifield IMRT treatments using the Corvus system. The first case was an IMRT treatment of prostate cancer, where the targets consisted of a prostate and seminal vesicle of the patient. Six coplanar beams ͑gantry angles of these fields are 0°, 55°, 145°, 180°, 215°, and 305°, respectively͒ were used for the treatment and the corresponding intensity maps are shown in Fig. 3 . The second case was an advanced stage prostate cancer with involvement of pelvic lymph nodes. This plan also used six coplanar beams, two of which were split into two beams since the field widths were larger than the maximum extension of the MLC ͑14.5 cm͒. The corresponding gantry angles for this treatment are 0°, 40°, 115°, 180°, 245°, and 320°, respectively. The intensity maps are shown in Fig. 4 .
The doses at different spatial points in the Lucite phantom were measured using a 0.147 cm 3 IC-10 ionization chamber ͑Wellhöffer Dosimetric, Schwarzenbruck, Germany͒ following the recommendations of AAPM TG-51. 29 No corrections were made for the variation in the chamber replacement effect. The results of the CORVUS planning, our independent calculations, and the measurements were compared for both groups of tests. Figure 5 shows the comparison of the absolute dose profiles along the midline of the 21st leaf pair in the isocenter plane at 5.0 cm depth ͑SSDϭ95 cm͒ in the cubic phantom for the four testing fields shown in Fig. 2 . Except for Fig.  5͑a͒ , in which no Corvus result is shown, three groups of data are presented: film measurements ͑solid lines͒, Corvus results ͑crossϩlines͒, and our calculations ͑scattered solid circles͒. The three sets of data agree to within Ϯ3.0% in most parts of the high dose regions. It is also intriguing to note that good agreement is found in the low dose and penumbra regions of the fields, which indicates that the head scatter radiation has been modeled adequately in our algorithm since the doses in these regions arise mainly from the FIG. 5 . Dose profiles along the midline of the 21st leaf pair obtained by using film measurements, Corvus planning system, and the current independent calculation for the four test intuitive fields: ͑a͒ a uniform open field formed by five 2ϫ10 cm 2 subfields; ͑b͒ a wedge field formed by MLC; ͑c͒ a pyramid field; and ͑d͒ an inverse pyramid field. The measurements and calculations were done in the isocenter plane at depth 5.0 cm in a water-equivalent phantom.
III. RESULTS
A. Single testing fields on a cubic water equivalent phantom
head scatter and phantom scatter. The absolute dose profiles at depth 10.0 cm with SSDϭ95 cm along the midline of the 21st leaf pair for the wedge ͓Fig. 2͑b͔͒, pyramid ͓Fig. 2͑c͔͒, and inverse pyramid ͓Fig. 2͑d͔͒ shaped field are shown in Fig. 6 . Similar levels of agreement are found for these fields. Figure 7͑a͒ shows the intensity map of a treatment field from a clinical IMRT case. The absolute dose profiles along the four lines marked in Fig. 7͑a͒ were computed using our algorithm in the isocenter plane at 3.0 cm depth ͑SSDϭ97 cm͒ in the cubic water equivalent phantom, and the results are shown in Figs. 7͑b͒, 7͑c͒, 7͑d͒ , and 7͑e͒ as solid dots. The film measurements and Corvus calculations were also performed in the phantom. While the overall agreement between our calculations, the Corvus plans, and the ion chamber measurements is excellent, there are regions ͑region A, B, C in Fig. 7͒ , where the dosimetric discrepancies between the three are more than 5%. In these regions, it seems that our program yielded closer doses to the measured values in comparison with that of the Corvus calculation. Furthermore, as can be seen from Fig. 7 , the penumbra regions are modeled adequately by our calculation. We believe that the better agreement with the measurements is a direct consequence of the use of a more accurate head scatter model.
B. Multifield IMRT plans
The dosimetric validation for the two multifield IMRT plans was performed on the cylindrical Lucite phantom. Using the RTP files of the surrogate Lucite phantom plans, we independently computed the doses at eight preselected spatial points inside the phantom for each plan. In selecting the calculation points, we have intentionally distributed them in high, medium, and relatively low dose regions, respectively, in order to have a complete coverage of all possible scenarios. The coordinates of the points of interest relative to the isocenter are listed in Tables I and II for both cases.  Table I summarizes the absolute doses from our calculations, Corvus plans and the measurements for the first case. Our calculations agree with the measurements to within 3.0% for all the eight verification points. The agreement between our calculations and the Corvus plans are also within 3.0% for all the points except point 5. At point 5, the devia- FIG. 6 . Dose profiles at depth 10.0 cm with SSDϭ95 cm in solid water along the midline of the 21st leaf pair for three test intuitive fields: ͑a͒ a wedge field; ͑b͒ a pyramid field; and ͑c͒ an inverse pyramid field.
tion of the Corvus dose from the measurement was found to be 5.6%, whereas our calculated dose for the point is only 0.6% different from the measured value. Table II lists the three sets of data for case 2. In this case, it was found that our calculations agreed with ion chamber measurements to within 3% for five out of the eight points.
The relative errors of our independent calculations with respect to the measurements at the remaining three points were above 3.0% but less than 5.0%. We also noticed that there are three points ͑points 3, 4, 5 in Table II͒ , where the errors of the Corvus calculations against the measurements were quite large: 5.6%, 11.8%, and 7.8%, respectively. The dis- FIG. 7 . A comparison of our calculations with ion chamber measurements and a Corvus plan for a clinical intensity modulated field. The intensity map of the field and the four lines along which the doses were compared are shown in ͑a͒. The absolute dose profile for line-1, -2, -3, and -4 are shown in panels ͑b͒, ͑c͒, ͑d͒, and ͑e͒, respectively. crepancies of our calculations from the measurements for the three points are Ϫ4.6%, 1.1%, and Ϫ4.6%, respectively, which are much closer to the measurements. We attribute once again the superior performance of our system to the better modeling of the head scatter. We note that point 4 is located in a high dose gradient region, where a more accurate point dose measurement technique is necessary for the conclusive comparison.
We also compared the calculated doses with and without head scatter correction at all test points for the two cases and found that the average difference is about 4% for the points in case 2 ͑large field IMRT͒ and about 2% for those in case 1 ͑small field IMRT͒. These results indicate the importance of head scatter in IMRT, in particular, IMRT with large fields, and strongly suggest that the head scatter correction should be included in plan validation algorithms.
IV. DISCUSSION
The dose verification is mainly done by experimental measurements in current practice. A drawback of the approach is that it is time consuming and manpower intensive. Clinically, the task of carrying out the patient specific plan validation becomes quite burdensome as the number of IMRT patients increases to more than two or three per week and this has become a major bottleneck problem in IMRT implementation. Just like that in the conventional 3-D conformal radiation therapy, an independent dose calculation may be a more practical approach for the patient-specific QA of IMRT. While the basic philosophy is similar, there are a few issues specific to IMRT that must be resolved in order to have a truly reliable computer-based plan validation tool.
First of all, we wish to stress that the conventional approach based on point dose verification is not enough to validate an IMRT plan. 15 To have a comprehensive understanding of the issue here, let us start by discussing the independent dosimetric verification procedure in conventional 3-D conformal radiation therapy ͑CRT͒. In CRT, the verification is mainly concerned with the MU calculation for each incident field. An independent calculation of the dose or MU at a point based on primitive machine data is recommended by AAPM TG-40. 30 Because the fluence of a uniform/ wedged field is spatially correlated, information of the dose at a spatial point can, in principle, be used to estimate the dose in other spatial points, provided that the off-axis information is known. This is, however, not the case for an intensity modulated field since the weights of the beamlets across the field are independent. The correctness of the dose at a spatial point only warrants, at most, the correctness of the beamlets passing through or nearby that point. As shown in Table I and Table II , although the dose discrepancies between the Corvus calculations and the measurements are all within 2.0% at the isocenter for the two clinical cases, the dose discrepancies in the off-axis positions may be much larger. To ensure that the final dose distribution adheres to the plan, a dosimetric check at multiple points should be an integral part of patient-specific QA to take into consideration the independence of the beamlets. An independent fluence map measurement/calculation would also be useful to remedy the uncertainty caused by the insufficient number of vali- dation points and provide additional assurance. In order to compute the spatial doses of an IMRT field, it is critical to model the MLC transmission and head scatter accurately because beamlet intensities are varied by moving MLC leaves across the irradiation field and a spatial point may often be at the edge͑s͒ of one or more segmented fields. In this work, the head scatter contribution is calculated by using a well-established three-source model. This makes it possible to accurately compute the point doses at an arbitrary spatial point in a phantom or patient.
V. CONCLUSION
The level of quality in IMRT treatment is the result of many factors, but at this point, perhaps no factor has such a far-reaching effect as the timely development of computerbased QA tools. With more and more hospitals starting their IMRT programs, it becomes increasingly important to have effective QA tools ready in the clinics. Otherwise, the gain from IMRT may be lost in a nonoptimal QA procedure and/or be offset by the increased cost of treatment. In this paper, an effective dose verification algorithm has been developed for IMRT treatment plan validation. The algorithm separates the primary and scatter radiation calculations. A modified Clarkson method is employed to compute the scatter dose contributions. A salient feature of the algorithm is the accurate inclusion of head scatter and MLC transmission. The inclusion of head scatter allows us to compute the IMRT dose, not only at the central-axis point, but also an arbitrary off-axis point. Given the relative simplicity and accuracy, the algorithm seems to balance the practicality and precision required by an IMRT plan validation tool and is thus valuable to greatly facilitate the routine clinical IMRT QA process.
